I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Al-Sarayfi, Diana
11
results:
Search for persons
X
Format
Online (11)
Mediatypes
Articles (Online) (4)
OpenAccess-fulltext (7)
Sorted by: Relevance
Sorted by: Year
?
1
P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DI..:
Al-Sarayfi, Diana
;
Brink, Mirian
;
Chamuleau, Martine E. D.
...
HemaSphere. 7 (2023) S3 - p. e48093ff , 2023
Link:
https://doi.org/10.1097/..
?
2
R-CEOP as first-line treatment for anthracycline-ineligible..:
Al-Sarayfi, Diana
;
Meeuwes, Frederik O.
;
Durmaz, Müjde
...
Blood Cancer Journal. 12 (2022) 9 - p. , 2022
Link:
https://doi.org/10.1038/..
?
3
Successful treatment of hairy cell leukemia variant with ob..:
Al-Sarayfi, Diana
;
Meeuwes, Freek O.
;
Munnink, Thijs Oude
...
Annals of Hematology. 101 (2021) 3 - p. 703-704 , 2021
Link:
https://doi.org/10.1007/..
?
4
P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DI..:
Al-Sarayfi, Diana
;
Brink, Mirian
;
Chamuleau, Martine E. D
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431034/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
R-CEOP as first-line treatment for anthracycline-ineligible..:
Al-Sarayfi, Diana
;
Meeuwes, Frederik O
;
Durmaz, Müjde
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440142/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
6
R-CEOP as first-line treatment for anthracycline-ineligible..:
Al-Sarayfi, Diana
;
Meeuwes, Frederik O
;
Durmaz, Mujde
...
https://research.rug.nl/en/publications/410a767d-8aa7-4fc1-a264-90c5c7657fa8. , 2022
Link:
https://hdl.handle.net/1..
?
7
Successful treatment of hairy cell leukemia variant with ob..:
Al-Sarayfi, Diana
;
Meeuwes, Freek O
;
Munnink, Thijs Oude
...
https://research.rug.nl/en/publications/a7664ab0-8db6-474b-bb9e-edfdc2eb5cba. , 2022
Link:
https://hdl.handle.net/1..
?
8
Successful treatment of hairy cell leukemia variant with ob..:
Al-Sarayfi, Diana
;
Meeuwes, Freek O
;
Munnink, Thijs Oude
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810450/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DI..:
Diana Al-Sarayfi
;
Mirian Brink
;
Martine E. D. Chamuleau
...
http://journals.lww.com/10.1097/01.HS9.0000971532.48093.ff. , 2023
Link:
https://doi.org/10.1097/..
?
10
R-CEOP as first-line treatment for anthracycline-ineligible..:
Diana Al-Sarayfi
;
Frederik O. Meeuwes
;
Müjde Durmaz
...
https://doi.org/10.1038/s41408-022-00723-4. , 2022
Link:
https://doi.org/10.1038/..
?
11
P1170: INCIDENCE, TREATMENT AND OUTCOME OF PATIENTS WITH RI..:
Huisman, F.
;
Al-sarayfi, D.
;
Bellido, M.
...
HemaSphere. 6 (2022) - p. 1056-1057 , 2022
Link:
https://doi.org/10.1097/..
1-11
